BioID
PrivateLast Round
Spinoff
Jan 1, 1998
Company Overview
BioID is a cybersecurity and SaaS company that provides cloud-based biometric authentication software, including facial recognition and liveness detection.
Sector
Cybersecurity
Verticals
Digital Identity, Identity & Access, RegTech, Computer Vision
Business Model
B2B2C
Customer Profile
Usage-Based SaaS, Freemium, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BioID Comparables
Compare BioID with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| FaceTec | 83% | |
| iProov | 78% | |
| Paravision | 78% |
BioID Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Spinoff | Jan 1, 1998 |
Key People
Founding team and executive leadership
BioID Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Fraunhofer Venture | Spinoff |
| Triangle Venture Capital Group | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 24, 2026
Grew 88% QoQ, from 8 to 15 employees.
- Jan 21, 2026
Monthly visitors increased 45% MoM, reaching 61K.
BioID Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about BioID's valuation, stock price, and market status.
Is BioID a public or private company?
BioID is a private company.
What is the current stock price of BioID?
BioID is a private company with no public stock price. No recent secondary market data is available.
How much is BioID worth (valuation)?
Valuation information for BioID is not publicly available.
Can I buy BioID stock?
BioID shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was BioID's last funding round?
BioID's most recent funding round was Spinoff on January 1, 1998.
Who are the main investors in BioID?
Key investors in BioID include Fraunhofer Venture, Triangle Venture Capital Group.
Will BioID IPO soon?
No public IPO plans have been announced for BioID.
How can I track BioID secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor BioID's secondary market activity and sign up for updates.